Dr. Maurice C Kuttab, M.D. Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 29th Ave N, Nashville, TN 37203 Phone: 615-818-7508 Fax: 615-327-0538 |
Dr. Saumya Goel Aujla, MD Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 |
Dr. Phillip L. Beaulieu Jr., M.D. Pain Medicine - Pain Medicine Medicare: Medicare Enrolled Practice Location: 310 25th Ave N Ste 203, Nashville, TN 37203 Phone: 615-815-1560 Fax: 615-610-1199 |
News Archive
Ron DePinho, M.D., president of The University of Texas MD Anderson Cancer Center, will be inducted as a new fellow of the American Association for Cancer Research Academy. He joins 10 other cancer leaders in the prestigious academy that recognizes people who have made significant contributions to cancer research.
Vortioxetine (trade name: Brintellix) has been approved since December 2013 for the treatment of depression in adults, but did not become actually available before May 2015. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier because it contained no data evaluable for the assessment.
Fatigue and pain, along with other symptoms, prevent many people with multiple sclerosis (MS) from exercising. But a new how-to guide for a home-based exercise program, tested by researchers at Case Western Reserve University's nursing school and the Lerner Research Institute at the Cleveland Clinic, offers a way for people with MS to stay more physically active.
Researchers at Brown University and Women & Infants Hospital have invented the first artificial human ovary, an advance that provides a potentially powerful new means for conducting fertility research and could also yield infertility treatments for cancer patients. The team has already used the lab-grown organ to mature human eggs.
Digna Biotech and Biotecnol announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I.
› Verified 2 days ago